Author: m.shaarawy@technic-eg.com

• m.shaarawy@technic-eg.com
• August 16, 2025
• Industry
• 0 Comments

Egypt’s Vaccine and Biotechnology City is a national project to localize human and veterinary vaccine production.

• m.shaarawy@technic-eg.com
• June 24, 2025
• Industry
• 0 Comments

Vaccines and Biotechnology City (VBC) participated in Africa Health ExCon 2025, Africa’s largest healthcare exhibition, showcasing its strategic vision for vaccine development, local manufacturing.

• m.shaarawy@technic-eg.com
• March 20, 2025
• Industry
• 0 Comments

The Egyptian Drug Authority discusses cooperation with Uganda’s Ministry of Health and VBC

• m.shaarawy@technic-eg.com
• December 8, 2024
• Industry
• 0 Comments

A WHO delegation visits Egypt’s Vaccines and Biotechnology City in Cairo.

• m.shaarawy@technic-eg.com
• November 28, 2024
• Industry
• 0 Comments

Launch of the Egyptian Vaccine Manufacturers Alliance to enhance health security.

• m.shaarawy@technic-eg.com
• February 13, 2023
• Industry
• 0 Comments

The Governor of Ismailia is following up on the executive position of the vaccine and serum production project.

• m.shaarawy@technic-eg.com
• December 12, 2022
• Industry
• 0 Comments

Global organizations from diverse nationalities visited Vaccines and Biotechnology City.

• m.shaarawy@technic-eg.com
• December 12, 2022
• Industry
• 0 Comments

Prime Minister Mostafa Madbouli visited Vaccine and Biotechnology City to follow up the work of implementing the projects.

• m.shaarawy@technic-eg.com
• December 4, 2022
• Industry
• 0 Comments

During the celebration, Mr. Hossam Heiba, CEO of The General Authority for Investment

• m.shaarawy@technic-eg.com
• June 13, 2022
• Industry
• 0 Comments

Vaccines Biotechnology City produces 140 million doses of human vaccines in addition to another 5.2 billion doses of veterinary vaccine annually.